Results 11 to 20 of about 2,281 (168)
Recurrent pityriasis rosea: A case report
Human Vaccines & Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
doaj +2 more sources
Pityriasis Rosea Like Drug Rash – A Need to Identify the Disease in Childhood [PDF]
Journal of Clinical and Diagnostic Research, 2014 Pityriasis rosea is a common dermatosis named by Gibert in 1860. It is an acute self limiting papulosquamous disease, probably infective in origin affecting healthy adolescents and young adults.
Maitreyee Panda +4 more
doaj +1 more source
Clinical and pathological features of 5 cases of children pigmento-genes pityriasis rosea
Pifu-xingbing zhenliaoxue zazhi, 2022 Objective To analyze clinical manifestations and histopathological features of children patients with pigmento-genes pityriasis rosea. Methods Clinical manifestations, histopathological features and therapeutic responses were retrospectively analyzed for
Ting ZHANG +5 more
doaj +1 more source
Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. [PDF]
Clin Dermatol, 2022 Drago F, Broccolo F, Ciccarese G.
europepmc +2 more sources
Pityriasis Rosea Induced by COVID-19 Vaccination
European Journal of Case Reports in Internal Medicine, 2022 It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect ...
Elina Khattab +2 more
doaj +1 more source
A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: Pityriasis rosea is an acute self-limiting skin disorder of unknown aetiology. Recently human herpes virus 6 and 7 has been hypothesized to be the cause of pityriasis rosea. Objective: To determine the efficacy of acyclovir, an anti-viral
Satyaki Ganguly
doaj +1 more source
Pityriasis Rosea After Pfizer-BioNTech Covid-19 Vaccine: A Case Report
Turkish Journal of Internal Medicine, 2022 After the pandemic started, vaccines against SARS-CoV-2 were developed and applied in a short time. Later, various side effects were reported during the use of these vaccines.
Şeyma Handan Akyön, Yeşer Genç
doaj +1 more source
Dermatology Practical & Conceptual, 2016 Background: Pityriasis rosea is a papulosquamous disease. It may occur during pregnancy; in this setting, it has occasionally been associated with adverse outcomes. Purpose: A woman who developed pityriasis rosea at the beginning of her eighth week of
Tiffany Y. Loh, Philip R. Cohen
doaj +1 more source
Unilateral pityriasis rosea in a child: A rare clinical presentation
The Turkish Journal of Pediatrics, 2017 Pityriasis rosea is a common papulosquamous disorder with occasional variations in lesion morphology, distribution, number and course of disease. The lesions are classically arranged with their long axes parallel to the Langer`s lines of cleavage and ...
Atiye Oğrum
doaj +1 more source